CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

AlloStimWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D014777 Virus Diseases NIH 0.12

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Safety and Efficacy of ALLOSTIM® Universal Anti-Viral Immunodulatory Vaccine for Healthy Elderly Adults

This protocol tests the safety and efficacy of a novel universal vaccine concept called "allo-priming" which is designed to protect elderly adults from progression of any type of viral infection, including possible protection against progression of the current outbreak of COVID-19 infection, and any future variants, strains, mutations of the causative SARS-CoV-2 virus as well as protection from any future currently unknown newly emergent novel viruses.

NCT04441047 Virus Diseases Drug: AlloStim
MeSH:Virus Diseases

Primary Outcomes

Description: vaccine events such as fever, rash, abnormal vital signs

Measure: frequency of vaccine events

Time: day 0 to day 28

Description: measurement of Th1/Th2 balance, allo-specific Th1/CTL response

Measure: Proportion of subjects with positive T-cell response

Time: day 0 to 1 year

Description: ex-vivo challenge of blood samples with live virus including SARS-CoV-2, influenza A and B

Measure: Proportion of subjects able to suppress viral propagation

Time: day 0 to 1 year

No related HPO nodes (Using clinical trials)